Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith S Kaye

Showing results (61-70 of 421) with videos related to

Pageof 43
Sort By:
The American Journal of the Medical Sciences|November 27, 2002
Utility of pulse oximetry in diagnosing pneumonia in nursing home residentsKeith S Kaye, Malini Stalam, Wendy E Shershen, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2025
New Perspectives on Antimicrobial Agents: Sulbactam-durlobactamJason M Pogue, Jeffrey Harrington, Walaiporn Wangchinda, et al.
Emerging Infectious Diseases|June 23, 2004
Reference group choice and antibiotic resistance outcomesKeith S Kaye, John J Engemann, Essy Mozaffari, et al.
Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve MonitoringJack Chang, Jiajun Liu, Keith S Kaye, et al.
The Lancet. Infectious Diseases|July 13, 2023
Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex - Authors' replyKeith S Kaye, Sarah M McLeod, John P O'Donnell, et al.
American Journal of Infection Control|August 23, 2015
Epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli among older adultsSachi Matsubayashi, Keith S Kaye, Sameen Farooq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
Expert Review of Anti-Infective Therapy|April 10, 2013
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and managementJason M Pogue, Tal Mann, Katie E Barber, et al.
Infectious Diseases and Therapy|March 31, 2017
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A ReviewJennifer N Lashinsky, Oryan Henig, Jason M Pogue, et al.
Pageof 43

Showing results (61-70 of 421) with videos related to

Sort By:
Pageof 43
The American Journal of the Medical Sciences|November 27, 2002
Utility of pulse oximetry in diagnosing pneumonia in nursing home residentsKeith S Kaye, Malini Stalam, Wendy E Shershen, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2025
New Perspectives on Antimicrobial Agents: Sulbactam-durlobactamJason M Pogue, Jeffrey Harrington, Walaiporn Wangchinda, et al.
Emerging Infectious Diseases|June 23, 2004
Reference group choice and antibiotic resistance outcomesKeith S Kaye, John J Engemann, Essy Mozaffari, et al.
Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve MonitoringJack Chang, Jiajun Liu, Keith S Kaye, et al.
The Lancet. Infectious Diseases|July 13, 2023
Sulbactam-durlobactam for infections caused by Acinetobacter baumannii-calcoaceticus complex - Authors' replyKeith S Kaye, Sarah M McLeod, John P O'Donnell, et al.
American Journal of Infection Control|August 23, 2015
Epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli among older adultsSachi Matsubayashi, Keith S Kaye, Sameen Farooq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
Expert Review of Anti-Infective Therapy|April 10, 2013
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and managementJason M Pogue, Tal Mann, Katie E Barber, et al.
Infectious Diseases and Therapy|March 31, 2017
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A ReviewJennifer N Lashinsky, Oryan Henig, Jason M Pogue, et al.
Pageof 43